Literature DB >> 25073283

[Risk factors of hidden blood loss in internal fixation of intertrochanteric fracture].

Yiling Zhang, Jing Shen, Zhi Mao, Anhua Long, Lihai Zhang, Peifu Tang.   

Abstract

OBJECTIVE: To analyze the associated risk factors of hidden blood loss in the internal fixation of intertrochanteric fracture.
METHODS: A retrospective analysis was made on the clinical data of 317 cases of intertrochanteric fractures which were treated by internal fixation between January 1993 and December 2008. There were 154 males and 163 females with an average disease duration of 4.58 days (range, 7 hours to 33 days); the age was (69.86 +/- 15.42) years; the average height was 1.64 m (range, 1.50-1.84 m); and the average weight was 62.26 kg (range, 39-85 kg). Of them, intramedullary fixation was used in 203 patients and extramedullary fixation in 114 patients. The operation time was (61.99 +/- 18.25) minutes. The red blood cell transfusion was given to 84 patients, and the transfusion amount was 200-1 000 mL. The drainage volume was 0-750 mL (mean, 61.85 mL). Hidden blood loss was calculated through change of hematocrit level before and after operation. The multiple linear regression was performed to analyse the risk factors of hidden blood loss.
RESULTS: The total blood loss was (918.60 +/- 204.44) mL, the hidden blood loss was (797.77 +/- 192.58) mL, and intraoperative visible blood loss was (257.32 +/- 271.24) mL. Single factor analysis showed hidden blood loss was significantly higher in variables as follows: gender, age, injury cause, fracture type, American anesthesiologists grading, anesthesia mode, hypertension, diabetes, disease duration, operation time, intraoperative transfusion of red blood cells, and fixation type. Multiple linear regression showed age, fracture type, anesthesia mode, and fixation type were significant risk factors.
CONCLUSION: The risk factors of hidden blood loss are advanced age (> 60 years), unstable fracture, general anesthesia, and imtramedullary fixation. Especially in elder patients with unstable fracture treated by intramedullary fixation under general anesthesia, hidden blood loss is more significant.

Entities:  

Mesh:

Year:  2014        PMID: 25073283

Source DB:  PubMed          Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi        ISSN: 1002-1892


  6 in total

1.  Comparison of Anesthetic Administration According to Method of Hip Surgery.

Authors:  Aysin Ersoy Esenyel; Cem Zeki Esenyel; Zekeriya Ervatan; Nuri Yakar; Mensure Cakirgoz; Ismail Kalkar; Metin Seyran
Journal:  Eurasian J Med       Date:  2017-01-25

2.  Effects of the ratios of marrow cavity diameter to intramedullary nail diameter from different layers on blood loss during perioperative period for femoral intertrochanteric fractures.

Authors:  Xiao Yu; Hong Zhang; Xiangxin Zhang; Renjie Xu; Yuanshi She; Zhaohen Yu; Guangxiang Chen
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

3.  An analysis of perioperative hidden blood loss in femoral intertrochanteric fractures: bone density is an important influencing factor.

Authors:  Haidong Cui; Kai Chen; Shujun Lv; Chaoqun Yuan; Youhua Wang
Journal:  BMC Musculoskelet Disord       Date:  2021-01-04       Impact factor: 2.362

Review 4.  Risk Factors for Perioperative Hidden Blood Loss After Intertrochanteric Fracture Surgery in Chinese Patients: A Meta-Analysis.

Authors:  Tao Wang; Junfei Guo; Zhiyong Hou
Journal:  Geriatr Orthop Surg Rehabil       Date:  2022-03-11

5.  Risk Factors Analysis and the Establishment of Nomogram Prediction Model of Hidden Blood Loss After Total Hip Arthroplasty for Femoral Neck Fracture in Elderly Women.

Authors:  Wei-Shi Hong; Ya-Xin Zhang; Qun Lin; Yu Sun
Journal:  Clin Interv Aging       Date:  2022-05-04       Impact factor: 3.829

6.  Unstable intertrochanteric fractures are associated with a greater hemoglobin drop during the perioperative period: a retrospective case control study.

Authors:  Po-Hsun Lin; Jui-Teng Chien; Jung-Pin Hung; Chih-Kai Hong; Tzung-Yi Tsai; Chang-Chen Yang
Journal:  BMC Musculoskelet Disord       Date:  2020-04-15       Impact factor: 2.362

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.